Added to YB: 2023-07-25
Pitch date: 2023-07-25
GMDA [bullish]
Gamida Cell Ltd.
-98.69%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Gamida Cell Ltd. researches, develops, and commercializes cell therapies. The company offers Omisirge (omidubicel-onlv), a cell therapy for use in treatment of patients with hematologic malignancies and severe aplastic anemia.
Market Cap
$2.6M
Pitch Price
$1.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.77
P/E
-0.04
EV/Sales
20.92
Sector
Biotechnology
Category
N/A
Show full summary:
GAMIDA CELL LTD GMDA
A summary for this pitch has not been created yet.
Read full article (0 min)